- Home
- LMND vs CNTA Comparison
LMND vs CNTA Comparison
Compare LMND & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LMND
- CNTA
- Stock Information
- Founded
- LMND 2015
- CNTA 2020
- Country
- LMND United States
- CNTA United Kingdom
- Employees
- LMND N/A
- CNTA N/A
- Industry
- LMND Property-Casualty Insurers
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- LMND Finance
- CNTA Health Care
- Exchange
- LMND Nasdaq
- CNTA Nasdaq
- Market Cap
- LMND 2.8B
- CNTA 2.3B
- IPO Year
- LMND 2020
- CNTA 2021
- Fundamental
- Price
- LMND $50.24
- CNTA $15.73
- Analyst Decision
- LMND Hold
- CNTA Strong Buy
- Analyst Count
- LMND 12
- CNTA 11
- Target Price
- LMND $36.33
- CNTA $30.60
- AVG Volume (30 Days)
- LMND 2.5M
- CNTA 1.0M
- Earning Date
- LMND 10-29-2025
- CNTA 08-12-2025
- Dividend Yield
- LMND N/A
- CNTA N/A
- EPS Growth
- LMND N/A
- CNTA N/A
- EPS
- LMND N/A
- CNTA N/A
- Revenue
- LMND $600,700,000.00
- CNTA $15,000,000.00
- Revenue This Year
- LMND $37.17
- CNTA N/A
- Revenue Next Year
- LMND $63.39
- CNTA N/A
- P/E Ratio
- LMND N/A
- CNTA N/A
- Revenue Growth
- LMND 27.51
- CNTA 118.88
- 52 Week Low
- LMND $15.27
- CNTA $9.60
- 52 Week High
- LMND $60.41
- CNTA $19.09
- Technical
- Relative Strength Index (RSI)
- LMND 48.69
- CNTA 41.51
- Support Level
- LMND $49.20
- CNTA $15.01
- Resistance Level
- LMND $52.41
- CNTA $17.68
- Average True Range (ATR)
- LMND 2.86
- CNTA 0.77
- MACD
- LMND -1.15
- CNTA -0.26
- Stochastic Oscillator
- LMND 17.28
- CNTA 23.00
About LMND Lemonade Inc.
Lemonade Inc operates in the insurance industry. The company offers digital and artificial intelligence based platform for various insurances and for settling claims and paying premiums. The platform ensures transparency in issuing policies and settling disputes. The company is using technology, data, artificial intelligence, contemporary design, and social impact to deliver delightful and affordable insurances. Geographically, it operates in California, Texas, New York, New Jersey, Illinois, Georgia, Washington, Colorado, Pennsylvania, Oregon and others.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.